Eric Bryant | Multibagger Research

"Isn't $LMND just another insurtech?" This chart can lay that argument to rest. Customers per employee, 2020–2025: $LMND vs. $ROOT vs. 7 major incumbents. $ROOT is the perfect test case. Same era. Same "insurtech" label. Same direct-to-consumer P&C model. Public company with clean data. $ROOT at 457 customers per employee. GEICO at 568. Progressive at 514. Root IS the incumbent band. Why? $ROOT innovation was telematics — better pricing through driving data. That helped them reach profitability. But it didn't change how many humans they need to operate. Root hired 341 people last year to add 73K policies. $LMND hired 47 to add 570K. That's not a difference of degree. It's a difference of kind. $LMND didn't just digitize the front end. AI Maya underwrites. AI Jim handles claims. The marginal customer costs almost nothing to serve. $ROOT used tech to price better. $LMND used AI to run the company. That's why one curve compounds and the other flatlines. This also kills the bear argument that competitors will "just copy $LMND playbook." $ROOT has been trying for 9 years. Backed by $1.2B+ in funding. Public since 2020. Building technology from scratch with no legacy constraints. And they still ended up in the incumbent band. If a well-funded, tech-native insurtech with zero legacy baggage can't replicate this efficiency curve, what makes anyone think State Farm or Allstate will? $LMND AI-first architecture isn't a feature. It's a compound advantage that gets harder to replicate every quarter — because every new customer, claim, and interaction feeds the models that make the next one cheaper to serve. The moat isn’t JUST the AI operating system running the company. It’s 3 million customers (and growing) training the AI.

$DUOL For fast gains, multiple expansion is what you are looking for. When I say fast I’m talking about a multibagger in 5 or less years.

@AlexBuys_ I should have included them for sure

@MultibaggerRsch MDA Space $MDA at 2.31 P/S

$RKLB $ASTS $SPCX $PL $SATL $FLY $BKSY $SPIR $VOYG $RDW $DUOT Forward P/S ratios for the most interesting space companies in the stock market. Caveats worth knowing: $RKLB excludes the pending Iridium acquisition ($5.9B, cash and stock) $PL reports on a January fiscal year, FY27 and FY28 mapped to 2026 and 2027 $VOYG closed Astrobotic July 13, consensus may not fully reflect it $ASTS dispersion is wide, management points toward $1B in 2027, which would be 21.8x $SPCX 2027 estimates span $54.8B to $85B, first public quarter reports in August $DUOT has 1-2 analysts and no 2027 consensus Source: S&P Global consensus estimates

@4Runna97 It’s fun watching him embarrass himself though 😂

This is your leader Cardano community 😂 Instead of simply saying “next question” he insults the guy and cries for a whole minute. Just goes to show how jealous and insecure he is about Ethereum being on top and Cardano sucking ass

@HolgerCardano24 Well said.

To be frank: IF you represent our ecosystem to some degree - and for some web2 people (Millions) etc. Charles is the only central point to look at (because Media does focus on him) - then you should respond normally without insulting people! He could make the same statement that he gets tired of being asked this question, BUT without insulting in this "i am the king and you are nobody"-style. BUT unfortunately our lovely Charles thinks he is better than EVERYONE else on the planet. Shame on you Charles, i will continue to vote with NO on every single thing you are involved in, until everyone understood that we should stop funnelling all money to a nasty, unfriendly, piece of shit - which works against his own ecosystem! Plus we do NOT need you! Imagine folks, the 160M (from this year) would have gone to builders that actually care about our ecosystem and not to the same guy who did not even delivered on what we paid him for last year.

@Mindset4Money_X The structure he’s created is still worth a premium. But I’d say maybe $60 to $80 or so without him the way space sentiment is right now. $RKLB is trading at a higher P/ 2026 sales.

@MultibaggerRsch Yes but let’s say he left today

$XPEV is very asymmetric here. I’m building it to a 1.5% position and the only Chinese exposure in my portfolio.

@RAWDII3 Definitely being patient and adding more

@MultibaggerRsch Just be patient. Short term manipulated by dealer and institutions

$HIMS $ENHA The peptide market by itself could be worth TRILLIONS. One category of peptide—GLP1s —are already a $100 billion market and they are still relatively early.

@JonasH00722429 Today that’s true. That was also true of GLPs just a few years ago. All we need are a few peptides half as effective as GLP1s

@MultibaggerRsch It's not worth trillions, that's for sure. Peptides ex GLP's not even 10 billion most likely.

@33Valleys If these really work anywhere near as effectively as GLP1s word of mouth alone will skyrocket the market.

@MultibaggerRsch When people figure out what they can do and know they are available, anyone with lingering injuries or recovering from something will consider it or buy it. We all know someone who has lingering injuries.

@georgitheagent Wild

@MultibaggerRsch 100 bil already is crazy

$TSLA $SPCX This is all very frustrating. But with all that being said… Never bet against Elon.

I’m adding to $TEM here at its 52 week lows.

$GHRS $CMPS $ATAI $DFTX $HELP I love psychedelics personally. I think they will save many lives as they are approved and go mainstream, but the asymmetry for psychedelic stocks isn’t that interesting anymore. $HELP is the only psychedelic stock that is very appealing as a potential multibagger at current valuations. I just sold out of my small $GHRS position as this market is offering better opportunities elsewhere.

$ATAI $GHRS $DFTX $CMPS $HELP They went nuclear. Now people are taking about it.

@cypherpunk31337 Well said.

@MultibaggerRsch All roads lead to Monero, brother.

I’d have to say that $XMR is my favorite crypto at this point. In all the BS and noise $XMR stayed true to the ethos of crypto and the original cypherpunk movement. After hundreds of thousands of shit coins $XMR stands alone.

@Matkinvest True

@MultibaggerRsch Guess people are VERY short term oriented

Who is selling $HIMS after 6/7 of the peptides were recommended?! I like the discount though

@low_IQ_trader Good call. I prefer investing over trading though.

@MultibaggerRsch I sold before because the price structure looked pretty weak